Apogee Therapeutics CMO Carl Dambkowski Sells Shares
Meno di 1 minuto di lettura
| Reporter Name | Dambkowski Carl |
| Relationship | Chief Medical Officer |
| Type | Sell |
| Amount | $139,801 |
| SEC Filing | Form 4 |
Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics, sold 3,860 shares of common stock on April 2, 2025, under a Rule 10b5-1 trading plan. The sales were executed at weighted average prices of $35.56, $37.03, and $37.59, resulting in a total sale amount of $139,801. Following these transactions, Dambkowski directly owns 247,173 shares of Apogee Therapeutics.
SEC Filing: Apogee Therapeutics, Inc. [ APGE ] - Form 4 - Apr. 04, 2025